Scilex Holding (SCLXW) Net Income towards Common Stockholders (QoQ) (2020 - 2026)

Scilex Holding (SCLXW) Net Income towards Common Stockholders (QoQ) (2020 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Scilex Holding - - 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -30.68%
Dec 31, 2025 87.13%
Sep 30, 2025 -198.90%
Jun 30, 2025 -229.99%
Mar 31, 2025 -69.85%
Dec 31, 2024 -249.93%
Sep 30, 2024 88.32%
Jun 30, 2024 -54.17%
Mar 31, 2024 -13.91%
Dec 31, 2023 75.73%
Sep 30, 2023 -230.87%
Jun 30, 2023 13.35%
Mar 31, 2023 -71.96%
Dec 31, 2022 -183.18%
Sep 30, 2022 220.53%
Jun 30, 2022 -95.10%
Mar 31, 2022 74.07%
Dec 31, 2021 -12,425.08%
Sep 30, 2021 -70.28%
Jun 30, 2021 -13.46%